Note*: This report requires 7-10 business days to complete.
DelveInsight’s Chemotherapy Induced Nausea and Vomiting - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Crohn’s disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Chemotherapy Induced Nausea and Vomiting forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Chemotherapy Induced Nausea and Vomiting till 2023.
Key Coverage and Benefits
• The report will help in developing business strategies by understanding the trends shaping and driving the global Chemotherapy Induced Nausea and Vomiting market.
• Identifying patient populations in the global “Chemotherapy Induced Nausea and Vomitingmarket to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Chemotherapy Induced Nausea and Vomiting therapeutics in each of the markets covered.
• To understand the future market competition in the global Chemotherapy Induced Nausea and Vomiting therapeutics market and Insightful review of the key market drivers and barriers.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
• It also provides Chemotherapy Induced Nausea and Vomiting for United States, EU5 and Japan from 2013 and forecasted Market to 2023.
'
Table of Contents
• Chemotherapy Induced Nausea and Vomiting overview
• Pathophysiology
• Symptoms of disease
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Chemotherapy Induced Nausea and Vomiting Market
• Global Epidemiology of Chemotherapy Induced Nausea and Vomiting Forecasted to 2023
• Global Market (2013-2015)
• Global Forecasted Market (2016-2023)
• Global Market by Geography
• Market of US (2013-2015)
• Forecasted Market of US (2016-2023)
• Market of Europe
• Market of Germany (2013-2015)
• Forecasted Market of Germany (2016-2023)
• Market of United Kingdom (2013-2015)
• Forecasted Market of United Kingdom (2016-2023)
• Market of France (2013-2015)
• Forecasted Market of France (2016-2023)
• Market of Italy (2013-2015)
• Forecasted Market of Italy (2016-2023)
• Market of Spain (2013-2015)
• Forecasted Market of Spain (2016-2023)
• Market of Japan (2013-2015)
• Forecasted Market of Japan (2016-2023)
• Market of ROW (2013-2015)
• Forecasted Market of ROW (2016-2023)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Chemotherapy Induced Nausea and Vomiting Drug Sales (USD Millions)-2023
• Table 6: Global Epidemiology of Chemotherapy Induced Nausea and Vomiting (2013-2023)
• Table 7: Chemotherapy Induced Nausea and Vomiting Global Market (USD Millions), (2013-2015)
• Table 8: Chemotherapy Induced Nausea and Vomiting Global Market (USD Millions), (2016-2023)
• Table 9: Chemotherapy Induced Nausea and Vomiting US Market (USD Millions), (2013-2015)
• Table 10: Chemotherapy Induced Nausea and Vomiting US Market (USD Millions), (2016-2023)
• Table 11: Chemotherapy Induced Nausea and Vomiting Germany Market (USD Millions), (2013-2015)
• Table 12: Chemotherapy Induced Nausea and Vomiting Germany Market (USD Millions), (2016-2023)
• Table 13: Chemotherapy Induced Nausea and Vomiting United Kingdom Market (USD Millions), (2013-2015)
• Table 14: Chemotherapy Induced Nausea and Vomiting United Kingdom Market (USD Millions), (2016-2023)
• Table 15: Chemotherapy Induced Nausea and Vomiting France Market (USD Millions), (2013-2015)
• Table 16: Chemotherapy Induced Nausea and Vomiting France Market (USD Millions), (2016-2023)
• Table 17: Chemotherapy Induced Nausea and Vomiting Italy Market (USD Millions), (2013-2015)
• Table 18: Chemotherapy Induced Nausea and Vomiting Italy Market (USD Millions), (2016-2023)
• Table 19: Chemotherapy Induced Nausea and Vomiting Spain Market (USD Millions), (2013-2015)
• Table 20: Chemotherapy Induced Nausea and Vomiting Spain Market (USD Millions), (2016-2023)
• Table 21: Chemotherapy Induced Nausea and Vomiting Japan Market (USD Millions), (2013-2015)
• Table 22: Chemotherapy Induced Nausea and Vomiting Japan Market (USD Millions), (2016-2023)
• Table 23: Chemotherapy Induced Nausea and Vomiting ROW Market (USD Millions), (2013-2015)
• Table 24: Chemotherapy Induced Nausea and Vomiting ROW Market (USD Millions), (2016-2023)
List of Figures
• Figure 1: Chemotherapy Induced Nausea and Vomiting Drug Sales (USD Millions)-2023
• Figure 2: Global Epidemiology of Chemotherapy Induced Nausea and Vomiting (2013-2023)
• Figure 3: Chemotherapy Induced Nausea and Vomiting Global Market (USD Millions), (2013-2015)
• Figure 4: Chemotherapy Induced Nausea and Vomiting Global Market (USD Millions), (2016-2023)
• Figure 5: Chemotherapy Induced Nausea and Vomiting US Market (USD Millions), (2013-2015)
• Figure 6: Chemotherapy Induced Nausea and Vomiting US Market (USD Millions), (2016-2023)
• Figure 7: Chemotherapy Induced Nausea and Vomiting Germany Market (USD Millions), (2013-2015)
• Figure 8: Chemotherapy Induced Nausea and Vomiting Germany Market (USD Millions), (2016-2023)
• Figure 9: Chemotherapy Induced Nausea and Vomiting United Kingdom Market (USD Millions), (2013-2015)
• Figure 10: Chemotherapy Induced Nausea and Vomiting United Kingdom Market (USD Millions), (2016-2023)
• Figure 11: Chemotherapy Induced Nausea and Vomiting France Market (USD Millions), (2013-2015)
• Figure 12: Chemotherapy Induced Nausea and Vomiting France Market (USD Millions), (2016-2023)
• Figure 13: Chemotherapy Induced Nausea and Vomiting Italy Market (USD Millions), (2013-2015)
• Figure 14: Chemotherapy Induced Nausea and Vomiting Italy Market (USD Millions), (2016-2023)
• Figure 15: Chemotherapy Induced Nausea and Vomiting Spain Market (USD Millions), (2013-2015)
• Figure 16: Chemotherapy Induced Nausea and Vomiting Spain Market (USD Millions), (2016-2023)
• Figure 17: Chemotherapy Induced Nausea and Vomiting Japan Market (USD Millions), (2013-2015)
• Figure 18: Chemotherapy Induced Nausea and Vomiting Japan Market (USD Millions), (2015-2023)
• Figure 19: Chemotherapy Induced Nausea and Vomiting ROW Market (USD Millions), (2013-2015)
• Figure 20: Chemotherapy Induced Nausea and Vomiting ROW Market (USD Millions), (2016-2023)
• Acacia Pharma Ltd.
• Aphios Corporation
• Genovate Biotechnology Co. LTD.
• Helsinn Holding S.A.
• Heron Therapeutics Inc.
• INSYS Therapeutics Inc.
• Kyowa Hakko Kirin Co. Ltd.
• Merck & Co. Inc.
• RedHill Biopharma Ltd.
• Shin Nippon Biomedical Laboratories Ltd.
• Sparsha Pharma International Pvt. Ltd.
• Suda Ltd
• Teikoku Pharma USA Inc.
• Tesaro Inc.
